May 6, 2016
This conference aimed to: (1) identify the various ways in which law and ethics intersect with the use of big data in health care and health research, particularly in the United States; (2) understand the way U.S. law (and potentially other legal systems) currently promotes or stands as an obstacle to these potential uses; (3) determine what might be learned from the legal and ethical treatment of uses of big data in other sectors and countries; and (4) examine potential solutions (industry best practices, common law, legislative, executive, domestic and international) for better use of big data in health care and health research in the U.S.
Panel 5, Oversight of Big Data Health Research: Proposals for Improvement:
- Laura Odwazny, Public Health Division, Office of the General Counsel, U.S. Department of Health and Human Services - Regulations Are Not the Barrier to Use of Big Data in Health Research: Tensions Between Privacy Lapses and “Minimal Risk”
- Liza Dawson, Research Ethics Team, Basic Sciences Program, Division of AIDS, NIAID/NIH/DHHS - The Common Rule and Research with Data, Big and Small
- Margaret (Mimi) Foster Riley, University of Virginia School of Law (and Robert J. Meyer) - Big Data, HIPAA, and the Common Rule: Time for Big Change?
- Moderator: Holly Fernandez Lynch, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School and the Center for Bioethics, Harvard Medical School
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School 2016 annual conference focused on “Big Data, Health Law, and Bioethics.” The conference was organized in collaboration with the Berkman Center for Internet & Society at Harvard University and the Health Ethics and Policy Lab, University of Zurich.
Learn more at petrieflom.law.harvard.edu/events/details/2016-annual-conference.